1
|
Kawamoto EM, Vivar C and Camandola S:
Physiology and pathology of calcium signaling in the brain. Front
Pharmacol. 3:612012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Oliveira AM and Bading H: Calcium
signaling in cognition and aging-dependent cognitive decline.
Biofactors. 37:168–174. 2011. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Carew TJ: Molecular enhancement of memory
formation. Neuron. 16:5–8. 1996. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lucchesi W, Mizuno K and Giese KP: Novel
insights into CaMKII function and regulation during memory
formation. Brain Res Bull. 85:2–8. 2011. View Article : Google Scholar
|
5
|
Berridge MJ: Calcium signalling and
Alzheimer's disease. Neurochem Res. 36:1149–1156. 2011. View Article : Google Scholar
|
6
|
Garwood C, Faizullabhoy A, Wharton SB,
Ince PG, Heath PR, Shaw PJ, Baxter L, Gelsthorpe C, Forster G,
Matthews FE, et al: MRC Cognitive Function and Ageing
Neuropathology Study Group: Calcium dysregulation in relation to
Alzheimer-type pathology in the ageing brain. Neuropathol Appl
Neurobiol. 39:788–799. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Pelizzoni I, Macco R, Morini MF, Zacchetti
D, Grohovaz F and Codazzi F: Iron handling in hippocampal neurons:
Activity-dependent iron entry and mitochondria-mediated
neurotoxicity. Aging Cell. 10:172–183. 2011. View Article : Google Scholar
|
8
|
Huang Y, Huang YL, Lai B, Zheng P, Zhu YC
and Yao T: Raloxifene acutely reduces glutamate-induced
intracellular calcium increase in cultured rat cortical neurons via
inhibition of high-voltage-activated calcium current. Neuroscience.
147:334–341. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang X, Dykens JA, Perez E, Liu R, Yang S,
Covey DF and Simpkins JW: Neuroprotective effects of
17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity
in human neuroblastoma SK-N-SH cells. Mol Pharmacol. 70:395–404.
2006.PubMed/NCBI
|
10
|
Zhu L, Luo Y, Chen T, Chen F, Wang T and
Hu Q: Ca2+ oscillation frequency regulates
agonist-stimulated gene expression in vascular endothelial cells. J
Cell Sci. 121:2511–2518. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hu Q, Deshpande S, Irani K and Ziegelstein
RC: [Ca2+](i) oscillation frequency regulates
agonist-stimulated NF-kappaB transcriptional activity. J Biol Chem.
274:33995–33998. 1999. View Article : Google Scholar : PubMed/NCBI
|
12
|
Dolmetsch RE, Xu K and Lewis RS: Calcium
oscillations increase the efficiency and specificity of gene
expression. Nature. 392:933–936. 1998. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Xu F, Hennessy DA, Lee TK and Syed NI:
Trophic factor-induced intracellular calcium oscillations are
required for the expression of postsynaptic acetylcholine receptors
during synapse formation between Lymnaea neurons. J Neurosci.
29:2167–2176. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kaech S and Banker G: Culturing
hippocampal neurons. Nat Protoc. 1:2406–2415. 2006. View Article : Google Scholar
|
15
|
Tsuruta F, Green EM, Rousset M and
Dolmetsch RE: PIKfyve regulates CaV1.2 degradation and prevents
excitotoxic cell death. J Cell Biol. 187:279–294. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Rosenegger D and Lukowiak K: The
participation of NMDA receptors, PKC, and MAPK in the formation of
memory following operant conditioning in Lymnaea. Mol Brain.
3:242010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Michel M, Green CL and Lyons LC: PKA and
PKC are required for long-term but not short-term in vivo operant
memory in Aplysia. Learn Mem. 18:19–23. 2011. View Article : Google Scholar :
|
18
|
Kornhauser JM, Cowan CW, Shaywitz AJ,
Dolmetsch RE, Griffith EC, Hu LS, Haddad C, Xia Z and Greenberg ME:
CREB transcriptional activity in neurons is regulated by multiple,
calcium-specific phosphorylation events. Neuron. 34:221–233. 2002.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Bito H, Deisseroth K and Tsien RW: CREB
phosphorylation and dephosphorylation: A Ca(2+) and stimulus
duration-dependent switch for hippocampal gene expression. Cell.
87:1203–1214. 1996. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kloskowska E, Malkiewicz K, Winblad B,
Benedikz E and Bruton JD: APPswe mutation increases the frequency
of spontaneous Ca2+ oscillations in rat hippocampal
neurons. Neurosci Lett. 436:250–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Flint AC, Dammerman RS and Kriegstein AR:
Endogenous activation of metabotropic glutamate receptors in
neocortical development causes neuronal calcium oscillations. Proc
Natl Acad Sci USA. 96:12144–12149. 1999. View Article : Google Scholar : PubMed/NCBI
|
22
|
Santos SF, Tasiaux B, Sindic C and Octave
JN: Inhibition of neuronal calcium oscillations by cell surface APP
phosphorylated on T668. Neurobiol Aging. 32:2308–2313. 2011.
View Article : Google Scholar
|
23
|
Santos SF, Pierrot N, Morel N, Gailly P,
Sindic C and Octave JN: Expression of human amyloid precursor
protein in rat cortical neurons inhibits calcium oscillations. J
Neurosci. 29:4708–4718. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Rui Y, Li R, Liu Y, Zhu S, Yu X, Sheng Z
and Xie Z: Acute effect of beta amyloid on synchronized spontaneous
Ca2+ oscillations in cultured hippocampal networks. Cell
Biol Int. 30:733–740. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
De Koninck P and Schulman H: Sensitivity
of CaM kinase II to the frequency of Ca2+ oscillations.
Science. 279:227–230. 1998. View Article : Google Scholar : PubMed/NCBI
|
26
|
Söderblom T, Laestadius A, Oxhamre C,
Aperia A and Richter-Dahlfors A: Toxin-induced calcium
oscillations: A novel strategy to affect gene regulation in target
cells. Int J Med Microbiol. 291:511–515. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Doody RS, Tariot PN, Pfeiffer E, Olin JT
and Graham SM: Meta-analysis of six-month memantine trials in
Alzheimer's disease. Alzheimers Dement. 3:7–17. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Liljelund P, Netzeband JG and Gruol DL:
L-type calcium channels mediate calcium oscillations in early
postnatal purkinje neurons. J Neurosci. 20:7394–7403.
2000.PubMed/NCBI
|
29
|
Biewenga E, Cabell L and Audesirk T:
Estradiol and raloxifene protect cultured SN4741 neurons against
oxidative stress. Neurosci Lett. 373:179–183. 2005. View Article : Google Scholar
|
30
|
Kawagoe J, Ohmichi M, Takahashi T, Ohshima
C, Mabuchi S, Takahashi K, Igarashi H, Mori-Abe A, Saitoh M, Du B,
et al: Raloxifene inhibits estrogen-induced up-regulation of
telomerase activity in a human breast cancer cell line. J Biol
Chem. 278:43363–43372. 2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Engdahl C, Jochems C, Gustafsson JA, van
der Saag PT, Carlsten H and Lagerquist MK: In vivo activation of
gene transcription via oestrogen response elements by a raloxifene
analogue. J Endocrinol. 203:349–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
32
|
Legault C, Maki PM, Resnick SM, Coker L,
Hogan P, Bevers TB and Shumaker SA: Effects of tamoxifen and
raloxifene on memory and other cognitive abilities: Cognition in
the study of tamoxifen and raloxifene. J Clin Oncol. 27:5144–5152.
2009. View Article : Google Scholar : PubMed/NCBI
|